EHMTI-0178. CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study
Crossref DOI link: https://doi.org/10.1186/1129-2377-15-S1-G10
Published Online: 2014-09-18
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Goadsby, P
Dodick, D
Spierings, E
Scherer, J
Sweeney, S
Grayzel, D
License valid from 2014-09-18